| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737140.4.1.105 |
| P698 | PubMed publication ID | 14748662 |
| P2093 | author name string | Herbert B Newton | |
| P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
| Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis | Q24313372 | ||
| Small molecule modulation of Smoothened activity | Q24540343 | ||
| Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened | Q24682703 | ||
| TOR, a central controller of cell growth | Q27933354 | ||
| Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine | Q28138510 | ||
| NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 | ||
| Identification of an amplified, highly expressed gene in a human glioma | Q28300727 | ||
| Expression and distribution of vascular endothelial growth factor protein in human brain tumors | Q28304035 | ||
| Cellular survival: a play in three Akts | Q29547806 | ||
| The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction | Q29618388 | ||
| Continuous release of endostatin from microencapsulated engineered cells for tumor therapy | Q31793485 | ||
| Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells | Q32084034 | ||
| Preclinical and clinical studies of MMP inhibitors in cancer | Q33692931 | ||
| Local endostatin treatment of gliomas administered by microencapsulated producer cells | Q33929689 | ||
| Phosphorylation of the PTEN Tail Acts as an Inhibitory Switch by Preventing Its Recruitment into a Protein Complex | Q34101673 | ||
| Clinical translation of angiogenesis inhibitors | Q34152769 | ||
| Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy | Q34157098 | ||
| Malignant glioma: genetics and biology of a grave matter. | Q34272357 | ||
| The rapamycin-sensitive signal transduction pathway as a target for cancer therapy | Q34293622 | ||
| PKB/AKT: functional insights from genetic models | Q34389540 | ||
| Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. | Q34439772 | ||
| Mechanisms and future directions for angiogenesis-based cancer therapies | Q34849057 | ||
| A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling | Q34863186 | ||
| Growth factors and cancer | Q36441643 | ||
| Function and regulation of ras. | Q40835314 | ||
| The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. | Q41120735 | ||
| Glioma invasion in the central nervous system | Q41131785 | ||
| smoothened encodes a receptor-like serpentine protein required for hedgehog signalling | Q42633905 | ||
| Medulloblastoma growth inhibition by hedgehog pathway blockade | Q44119270 | ||
| Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas | Q48486587 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 105-128 | |
| P577 | publication date | 2004-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Expert Review of Anticancer Therapy | Q2999044 |
| P1476 | title | Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis | |
| P478 | volume | 4 |
| Q34000631 | Advances in strategies to improve drug delivery to brain tumors |
| Q24655510 | Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy |
| Q42426022 | Akt2 and Akt3 play a pivotal role in malignant gliomas |
| Q40379752 | An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor |
| Q34568628 | Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model |
| Q33760569 | Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors |
| Q46678485 | CD117 expression in glial tumors |
| Q36677119 | Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion |
| Q36307802 | Chemotherapy for malignant glioma |
| Q37316986 | Combination therapy for malignant glioma based on PTEN status |
| Q39143478 | Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling |
| Q38401892 | Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor |
| Q36429731 | Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future |
| Q33907663 | Cytotoxic autophagy in cancer therapy |
| Q36764016 | Emerging monoclonal antibody therapies for malignant gliomas |
| Q36779651 | Emerging treatments and gene expression profiling in high-risk medulloblastoma |
| Q46427095 | Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue |
| Q45857497 | Gene therapy for malignant glioma |
| Q37974419 | General and neurological complications of targeted therapy |
| Q57720217 | Genetics of Pten Hamartoma Tumor Syndrome (PHTS) |
| Q81521004 | Glioblastoma multiforme |
| Q49719103 | Glioma infiltration and extracellular matrix: key players and modulators. |
| Q36033617 | Hedgehog Signaling Components Are Expressed in Choroidal Neovascularization in Laser-induced Retinal Lesion |
| Q35800467 | Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis |
| Q36764876 | Inhibiting kinases in malignant gliomas |
| Q37004664 | Inhibition of angiogenesis and invasion in malignant gliomas |
| Q35440540 | Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. |
| Q38089834 | Malignant glioma drug discovery – targeting protein kinases |
| Q79969984 | Malignant gliomas |
| Q36499234 | Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment |
| Q37018652 | Mechanisms of disease: the PI3K-Akt-PTEN signaling node--an intercept point for the control of angiogenesis in brain tumors |
| Q34631513 | Molecular Targets and Treatment of Meningioma |
| Q36478640 | Molecular biology of human gliomas |
| Q36066191 | Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway |
| Q36118431 | Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle |
| Q36582396 | Molecular therapies for malignant glioma |
| Q33644407 | Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies |
| Q36817109 | Molecularly targeted therapies for malignant gliomas: advances and challenges |
| Q37364700 | New strategies to deliver anticancer drugs to brain tumors |
| Q33747041 | Notch signaling in glioblastoma: a developmental drug target? |
| Q38569802 | Novel chemotherapeutics and other therapies for treating high-grade glioma |
| Q37808385 | PI3Kinase signaling in glioblastoma |
| Q51597378 | PTEN gene: a model for genetic diseases in dermatology. |
| Q26784590 | Phosphatase and Tensin Homologue: Novel Regulation by Developmental Signaling |
| Q34886884 | Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival. |
| Q37444920 | Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. |
| Q34191508 | Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas |
| Q48413426 | Relationship between PTEN gene expression and differentiation of human glioma |
| Q54384404 | Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells |
| Q36108621 | Small molecule and monoclonal antibody therapies in neurooncology |
| Q34132781 | Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies |
| Q33780701 | Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3 |
| Q45855175 | Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo |
| Q82494790 | Targeted molecular therapy of malignant gliomas |
| Q36113026 | Targeted molecular therapy of malignant gliomas |
| Q35234447 | Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin. |
| Q79635149 | The p53/p21 DNA damage-signaling pathway is defective in most meningioma cells |
| Q36485266 | The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas |
Search more.